Hepion Pharmaceuticals Rings the Closing Bell
About This Event
Hepion Pharmaceuticals (Nasdaq: HEPA), a biotechnology company headquartered in Edison, New Jersey developing a drug to combat fibrosis and NASH, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Dr. Robert Foster, CEO, rings the Closing Bell.